MIT immunoengineer Michal “Mikki” Tal remembers the exact moment she had an insight that would change the trajectory of her research, getting her hooked on studying a long-neglected disease that leaves millions of Americans suffering without treatment.  It was 2017, and she was a Stanford postdoc exploring connections between her immune regulation research and immuno-oncology,…